Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|November 7, 2020
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolismAnna Polak, Emilia Bialopiotrowicz, Beata Krzymieniewska, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 8, 2009
Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)Ewa Lech-Maranda, Marek Seweryn, Sebastian Giebel, et al.
Scientific Reports|November 17, 2022
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicityKavita Ramji, Tomasz M Grzywa, Anna Sosnowska, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 5, 2023
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research GroupEwa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, et al.
Molecular Oncology|March 13, 2019
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemiaKlaudyna Fidyt, Agata Pastorczak, Agnieszka Goral, et al.
Blood Neoplasia|January 15, 2026
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trialGiovanni Martinelli, Scott R Solomon, Sudipto Mukherjee, et al.
Redox Biology|December 22, 2018
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbateAgnieszka Graczyk-Jarzynka, Agnieszka Goral, Angelika Muchowicz, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
The Lancet. Oncology|December 10, 2020
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 studyJacob P Laubach, Fredrik Schjesvold, Mário Mariz, et al.
Leukemia & Lymphoma|November 14, 2014
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group studyBozena Katarzyna Budziszewska, Agnieszka Pluta, Kazimierz Sulek, et al.
Pageof 7